. 2021 Aug 26;26(17):5170. doi: 10.3390/molecules26175170
© 2021 by the authors.
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Figure 2.
AURK and PLK inhibitors in clinical trials.